Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Neurology|August 25, 2017
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapyEva Havrdova, Douglas L Arnold, Jeffrey A Cohen, et al.
Lancet (London, England)|November 6, 2012
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trialJeffrey A Cohen, Alasdair J Coles, Douglas L Arnold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2019
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow TransplantationJeffrey A Cohen, Laura E Baldassari, Harold L Atkins, et al.
The New England Journal of Medicine|August 7, 2020
Ofatumumab versus Teriflunomide in Multiple SclerosisStephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, et al.
The Lancet. Neurology|July 21, 2023
Differential diagnosis of suspected multiple sclerosis: an updated consensus approachAndrew J Solomon, Georgina Arrambide, Wallace J Brownlee, et al.
Nature Reviews. Neurology|January 15, 2025
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMTPaolo A Muraro, Alice Mariottini, Raffaella Greco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2020
Multiple sclerosis management during the COVID-19 pandemicBrandon P Moss, Kedar R Mahajan, Robert A Bermel, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: global health considerationsJorge Correale, Andrew J Solomon, Jeffrey A Cohen, et al.
Neurology. Clinical Practice|July 10, 2020
Technology-enabled assessments to enhance multiple sclerosis clinical care and researchGabrielle Macaron, Brandon P Moss, Hong Li, et al.
The Lancet. Neurology|December 26, 2017
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J Thompson, Brenda L Banwell, Frederik Barkhof, et al.
Pageof 23